Alveolus Bio Revenue and Competitors
Estimated Revenue & Valuation
- Alveolus Bio's estimated annual revenue is currently $1M per year.
- Alveolus Bio's estimated revenue per employee is $77,500
Employee Data
- Alveolus Bio has 13 Employees.
- Alveolus Bio grew their employee count by 8% last year.
Alveolus Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Associate Director Program Management | Reveal Email/Phone |
3 | Doctoral Student - Biotechnology | Reveal Email/Phone |
Alveolus Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Alveolus Bio?
Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Our clinical pipeline includes preclinical phase live biotherapeutics for Bronchopulmonary Dysplasia (BPD), Pulmonary Arterial Hypertension (PAH), Chronic Obstructive Pulmonary Disease (COPD), and Idiopathic Pulmonary Fibrosis (IPF).
keywords:N/A
N/A
Total Funding
13
Number of Employees
$1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 13 | N/A | N/A |
#2 | $2.4M | 13 | N/A | N/A |
#3 | $2M | 13 | -24% | N/A |
#4 | $1M | 13 | -52% | $10.3M |
#5 | $0.8M | 13 | -67% | $2.2M |